Young European Academy of Paediatrics

Officials & Members 

OFFICIALS

YOUNG EAP – TERMS OF REFERENCE

Core Group

Nora Karara

Germany

Chair of Young EAP | Young EAP Representative for Infection Control/Vaccination &  Young EAP Delegate, EAPRASnet Steering Committee

Nora Karara is a paediatric resident and global public health enthusiast, currently working in primary paediatric care in Berlin..

She is an active founding member of the Young German Society of Pediatrics and Adolescent Medicine and proud to be a be a part of the European Academy of Paediatrics. She currently also holds the position of Representative for Infection control and Prevention, is a member of the EAPRASnet committee and enjoys partaking in various Strategic Advisory Groups.

Nora is excited to be the new chair of YEAP and sees this as a great opportunity to improve paneuropean physicians’ training, promote child health and – together with her colleagues- bridge the gaps between our countries for a brighter European future in Paediatrics.

Siân Copley

United Kingdom

Vice Chair of Young EAP & Young EAP Representative for Advocacy

Siân is a 7th year paediatric resident currently based in the North West of the U.K. between the Royal Manchester Childrens Hospital and Alder Hey Childrens hospital. She is subspecialising in Paediatric
Gastroenterology, Hepatology and Nutrition. She has an interest in medical education, holding a masters degree in this field, and is keen to work on improving the quality of paediatric training and experience of paediatric trainees. As well as being secretary of Young EAP, Siân represents Young EAP within the EAP Advocacy working group and is passionate about improving health outcomes for children and advocating for them to be central to policy decisions.

Maša Brumec

Slovenia

Secretary of Young EAP

Maša is a second year pediatric resident currently living in Maribor, Slovenia. She started her academic journey at the Medical Faculty, University of Maribor, earning a medical degree in 2020. Embarking on a fulfilling career, she became a pediatric resident in 2022, contributing to primary care while engaging in rotations across various pediatric departments. Her passion lies in neonatology with a distinct preference for acute medical settings that demand critical thinking over sole memorization. She also enjoys working with preschool children in a primary care setting.

In 2023, she enthusiastically joined yEAP driven by a profound desire to connect with like-minded professionals and further enhance her expertise in pediatric medicine.

REPRESENTATIVES FOR EDUCATION AND ADVOCACY

Nomination form – Young EAP member

MEMBERS

Young EAP members are attending YEAP monthly meetings and are actively involved in achieving YEAP objectives. Members that are officially nominated the by their corresponding national society are full members of Young EAP and are able to vote on behalf of their country.

AUSTRIA

Anna Wollshlaege

Alia Ghazzawi

BELGIUM

Amber Van Baelen
Antwerp University Hospital

GERMANY

Nora Karara
Public Health, Berlin

HUNGARY

Zsofia Csizek
Department of Pediatrics, Semmelweis University, Budapest

Julia Erdi
Department of Pediatrics, Semmelweis University, Budapest

SLOVENIA

Nika Morgan

Masa Brumec
UKC Maribor

Türkiye

Berrak Nevin Öztosun

AZERBAIJAN

Shelale Polikhova

Guler Pirizade

Czech Republic

Sabina Pavlikova
Department of Pediatrics and Inherited Metabolic Disorders of the First Medical Faculty of Charles University and the General University Hospital

Veronika Pokorna
University Hospital Hradec Králové

ITALY

Antonio Corsello

Lorenza Onorati

PORTUGAL

Madalena von Hafe
Porto

David Gomes
Hospital do Espírito Santo de Évora

SPAIN

Arnau Álvarez Vila

UKRAINE

Veronika Letychevska,
Kyiv

BELARUS

Anna Lastovka

CROATIA

Ivan Jakopčić

Neno Poljak

FRANCE

Lea Lenglart
Pediatric Emergency department, robert Debré Hospital, Paris

Lea Linglart
Pediatric Cardiology Department, Necker Hospital, Paris

SERBIA

Marko Pavlovic

Milica Plazačić
Institute of Youth and Child Healthcare of Vojvodina, Novi Sad

SWEDEN

Elin Doyle

Niyat Negasi

UNITED KINGDOM

Debora Calderoni

Sian Copley

AUSTRIA

Anna Wollshlaege

Alia Ghazzawi

AZERBAIJAN

Shelale Polikhova

Guler Pirizade

BELARUS

Anna Lastovka

BELGIUM

Amber Van Baelen
Antwerp University Hospital

CROATIA

Ivan Jakopčić

Neno Poljak

Czech Republic

Sabina Pavlikova
Department of Pediatrics and Inherited Metabolic Disorders of the First Medical Faculty of Charles University and the General University Hospital

Veronika Pokorna
University Hospital Hradec Králové

FRANCE

Lea Lenglart
Pediatric Emergency department, robert Debré Hospital, Paris

Lea Linglart
Pediatric Cardiology Department, Necker Hospital, Paris

GERMANY

Nora Karara
Public Health, Berlin

HUNGARY

Zsofia Csizek
Department of Pediatrics, Semmelweis University, Budapest

Julia Erdi
Department of Pediatrics, Semmelweis University, Budapest

ITALY

Antonio Corsello

Lorenza Onorati

PORTUGAL

Madalena von Hafe
Porto

David Gomes
Hospital do Espírito Santo de Évora

SERBIA

Marko Pavlovic

Milica Plazačić
Institute of Youth and Child Healthcare of Vojvodina, Novi Sad

SLOVENIA

Nika Morgan

Masa Brumec
UKC Maribor

SPAIN

Arnau Álvarez Vila

SWEDEN

Elin Doyle

Niyat Negasi

Türkiye

Berrak Nevin Öztosun

UKRAINE

Veronika Letychevska,
Kyiv

UNITED KINGDOM

Debora Calderoni

Sian Copley

AUSTRIA

Anna Wollschlaeger

Alia Ghazzawi

CROATIA

MALTA

Jamie Grech

Alexandra Tortell

SWEDEN

Elin Doyle

Niyat Negasi

AZERBAIJAN

Shelale Polikhova

Guler Pirizade

Netherlands

Paula Roosendahl

Hugo Kraijenhoff

SERBIA

Marko Pavlovic

Milica Plazačić

Türkiye

Berrak Nevin Öztosun

Ovgü Büke

BELARUS

Anna Lastovka

 

ITALY

Antonio Corsello

Lorenza Onorati

 

Norway

Farhan Saleem Ud Din

 

SLOVENIA

Nika Morgan

Masa Brumec

UKRAINE

Veronika Letychevska

Anna Z

BELGIUM

GERMANY

Nora Karara
Julian Hantke

SPAIN

Arnau Álvarez Vila

 

UNITED KINGDOM

Debora Calderoni

Sian Copley

COLLABORATION WITH OTHER SECTIONS

EUROPE AND THE MEDICAL PROFESSION

European developments greatly impact the way in which medical specialists do their work and how junior doctors are being trained. Patients and health care professionals have the right to move freely within the European Union (EU). The freedom to receive services throughout the EU must be accompanied by guaranteed quality and safety. In addition, health care systems across Europe are increasingly inter-dependent and there is a tendency towards development of cross-border expert centers for rare diseases. As several health issues cannot be dealt with at the national level alone, the EU has an important role to play in improving public health, preventing and managing diseases, mitigating sources of danger to human health, and harmonising health strategies between European countries.The UEMS represents over 1.6 million medical specialists in all the different specialties. It also has strong links and relations with European Institutions (like the Commission and Parliament), the other independent European Medical Organisations and the European Medical / Scientific Societies. The UEMS sets standards for high quality healthcare practice that are transmitted to the Authorities and Institutions of the EU and the National Medical Associations stimulating and encouraging them to implement its recommendations. In addition, it operates at the European level to defend and promote the interests of Medical Specialists.

Through various bodies and structures, the UEMS represents more than 50 medical disciplines. The most important ones are the 43 Specialist Sections, which represent independently recognised specialties. The European Academy of Paediatrics (EAP/UEMS) is one of these Sections. The EAP consists of delegates from National Paediatric Societies, observers, UEMS Paediatric Subspecialty Societies and affiliated and related societies. Individuals (like paediatric trainees) can also become a member of the EAP.

Junior doctors in Europe are represented within the UEMS by representatives from the European Junior Doctors (EJD).

EUROPEAN REPRESENTATION OF PAEDIATRIC TRAINEES

The EJD represents over 300,000 junior doctors from all over Europe and has the objective to safeguard the interests of junior doctors in Europe by improving the working conditions and the mobility in the profession and setting standards regarding the quality of postgraduate medical training.The EJD send Representatives to the UEMS Boards, Sections and Multidisciplinary Joint Committees (MJC) as the input of doctors in training in the matters of postgraduate medical training is considered of paramount importance for both institutions. EJD representatives should also be part of the PGT visiting committees. The EAP has kindly invited the EJD for Paediatrics to be part of its Executive Committee and as such provide direct input to issues related to the promotion of European child health, the improvement of health standards and the European representation of professional interests.

The EAP recommends the standards for postgraduate training in paediatrics, advocates for children’s health across Europe, and represents the professional interests of paediatricians in Europe. In terms of medical training, the EAP/UEMS has the responsibility to promote harmonisation in paediatric training throughout its member states. Within the EAP, the European Board of Paediatrics (EBP) recommends the standards for specialist training in paediatrics and the maintenance of such standards. The EAP/UEMS is responsible for developing and updating curricula for paediatric training and the different recognized paediatric subspecialties. It is responsible for developing programs for the trainees and trainers, as well as accreditation for the teaching centres. EAP/UEMS is responsible for evaluation of the CME accreditations for the paediatric congresses and any form of new formats in postgraduate training in Europe. It is important to recognise that the national training standards within any country are determined by that country’s national training authority (NTA), although they should be guided by the recommendations that are endorsed by UEMS. Consequently, recommendations from the UEMS are not binding, but for many countries (both within and outside the EU) the European standards provide valuable support for the profession in maintaining adequate duration of training, and enabling the movement of professionals between countries.

The EAP is active in several advocacy areas, including antibiotic resistance, migrant health, chronic diseases (including obesity) and paediatric medicines. In these key areas, the EAP works closely with partners including the European Centre for Disease Prevention and Control, the International Society for Social Pediatrics and Child Health, and the European Public Health Alliance and with EAP subspecialty societies like the European Society for Paediatric Infectious Diseases and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. In addition, the EAP is member of the External Advisory Board of MOCHA (Models of Child Health Appraised), a study of paediatric primary healthcare in 30 European countries.

Presentation

Your Enquiries Are Welcome

We will respond to you by Email

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative: